WO2006026358A3 - Proteines associees a raft specifiques du sperme - Google Patents
Proteines associees a raft specifiques du sperme Download PDFInfo
- Publication number
- WO2006026358A3 WO2006026358A3 PCT/US2005/030261 US2005030261W WO2006026358A3 WO 2006026358 A3 WO2006026358 A3 WO 2006026358A3 US 2005030261 W US2005030261 W US 2005030261W WO 2006026358 A3 WO2006026358 A3 WO 2006026358A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- associated proteins
- sperm specific
- raft associated
- specific raft
- sperm
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Gastroenterology & Hepatology (AREA)
- Toxicology (AREA)
- Immunology (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Cell Biology (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Abstract
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US60461704P | 2004-08-25 | 2004-08-25 | |
US60/604,617 | 2004-08-25 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2006026358A2 WO2006026358A2 (fr) | 2006-03-09 |
WO2006026358A3 true WO2006026358A3 (fr) | 2009-05-07 |
Family
ID=36000577
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2005/030261 WO2006026358A2 (fr) | 2004-08-25 | 2005-08-25 | Proteines associees a raft specifiques du sperme |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2006026358A2 (fr) |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2000043495A2 (fr) * | 1999-01-19 | 2000-07-27 | Human Genome Sciences, Inc. | Proteines humaines secretees (33) |
-
2005
- 2005-08-25 WO PCT/US2005/030261 patent/WO2006026358A2/fr active Application Filing
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2000043495A2 (fr) * | 1999-01-19 | 2000-07-27 | Human Genome Sciences, Inc. | Proteines humaines secretees (33) |
Non-Patent Citations (1)
Title |
---|
SANCHEZ ET AL.: "Generation and initial analysis of more than 15,000 full-Iength human and mouse cDNA sequences.", NATURE., vol. 99, no. 26, December 2002 (2002-12-01), pages 16899 - 16903 * |
Also Published As
Publication number | Publication date |
---|---|
WO2006026358A2 (fr) | 2006-03-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2004047728A3 (fr) | Compositions et procedes destines au traitement de maladies de nature immune | |
WO2004039956A3 (fr) | Compositions et methodes de traitement de maladies liees au systeme immunitaire | |
WO2005019258A3 (fr) | Compositions et methodes de traitement de maladies relatives au systeme immunitaire | |
WO2005032471A3 (fr) | Inhibiteurs de type benzylether et benzylamino de beta-secretase pour le traitement de la maladie d'alzheimer | |
WO2003000113A3 (fr) | Compositions et procedes destines au diagnostic et au traitement de tumeurs | |
WO2003088808A3 (fr) | Compositions et methodes permettant de diagnostiquer et de traiter une tumeur | |
WO2006029183A3 (fr) | Compositions et procedes pour le diagnostic et le traitement d'une tumeur | |
WO2005004803A3 (fr) | Inhibiteurs de la beta-secretase de phenylcarboxylate destines au traitement de la maladie d'alzheimer | |
WO2004001019A3 (fr) | Nouvelles nanoparticules et leur utilisation | |
WO2002074337A8 (fr) | Inhibiteurs et/ou antagonistes de proteines hmgb1 destines au traitement de maladies vasculaires | |
HK1162127A1 (en) | Oil body associated protein compositions and methods as well as use thereof for reducing the risk of cardiovascular disease | |
WO2003099771A3 (fr) | Derives de diaryle-uree utilises pour le traitement des maladies dependant des proteines kinases | |
EP1445317A3 (fr) | Compositions et procédés de diagnostic et traitement de tumeurs | |
UA94221C2 (en) | Lipocalin protein | |
WO2004024068A3 (fr) | Nouvelles composition et methodes servant au traitement de maladies associees au systeme immunitaire | |
WO2006110760A3 (fr) | Compositions et methodes de diagnostic et de traitement de tumeur | |
WO2005018545A3 (fr) | Inhibiteurs macrocycliques de la beta-secretase destines au traitement de la maladie d'alzheimer | |
AU2003290605A8 (en) | Compositions and methods for the diagnosis and treatment of sepsis | |
WO2002016581A3 (fr) | Compositions et methodes pour le diagnostic et le traitement de tumeurs | |
WO2004024063A3 (fr) | Compositions et procede de diagnostic et de traitement des tumeurs | |
WO2004024072A3 (fr) | Nouvelles compositions et methodes pour le traitement de maladies associees au systeme immunitaire | |
WO2002016602A3 (fr) | Compositions et procedes conçus pour le diagnostic et le traitement de tumeur | |
WO2002067771A3 (fr) | Recepteurs de chimiokine et maladies associees | |
WO2004096124A3 (fr) | Compositions et procedes pour le diagnostic et le traitement de tumeurs | |
WO2004006911A3 (fr) | Compositions destinees au traitement des neuropathies peripheriques, preparation et utilisations |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KM KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NG NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SM SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU LV MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |